Literature DB >> 12459912

Ligand effects on the binding of cis- and trans-[PtCl(2)Am(1)Am(2)] to proteins.

Yousef Najajreh1, Tal Peleg-Shulman, Ofra Moshel, Nicholas Farrell, Dan Gibson.   

Abstract

As part of a systematic study of the basic principles that govern the formation and reactivity of Pt-protein adducts, we report the effect of substituting the amine ligand of cis- and trans-[PtCl(2)(NH(3))(2)] complexes with bulkier planar aromatic or nonplanar cyclic amine ligands on the binding properties of the complexes to ubiquitin and to horse heart myoglobin. The ligand replacement had a different effect on the cis or trans isomers investigated. In the cis-Pt complexes, replacing one or both amine ligands by piperidine or 4-picoline dramatically decreased the binding of the complexes to the proteins studied, whereas in the substituted trans-Pt complexes replacement of the amine by a piperidine or 4-picoline increased the binding rate. This behavior may have to do with the different preferred binding sites of the cis- and trans-Pt complexes. The bulkier cis- or trans-Pt complexes investigated also did not display a preference for Met1 of ubiquitin, possibly owing to steric constraints imposed by the substituted ligands. The introduction of a charged piperazine ligand significantly decreased the rate of binding to the protein, possibly owing to electrostatic interactions or hydrogen-bond formations with the surface of the protein. The binding of the complexes to ubiquitin and myoglobin does not disrupt the folding of the proteins as judged by electrospray ionization mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459912     DOI: 10.1007/s00775-002-0402-y

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  5 in total

1.  Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.

Authors:  Zhengyi Wu; Qin Liu; Xiao Liang; Xiaoliang Yang; Ningyan Wang; Xinghao Wang; Hongzhe Sun; Yi Lu; Zijian Guo
Journal:  J Biol Inorg Chem       Date:  2009-08-08       Impact factor: 3.358

2.  Palladium(II) and platinum(II) bind strongly to an engineered blue copper protein.

Authors:  Matthew P McLaughlin; Thomas H Darrah; Patrick L Holland
Journal:  Inorg Chem       Date:  2011-10-25       Impact factor: 5.165

3.  Towards Antitumor Active trans-Platinum Compounds.

Authors:  Sheena M Aris; Nicholas P Farrell
Journal:  Eur J Inorg Chem       Date:  2009-04-01       Impact factor: 2.524

4.  Comparative cisplatin reactivity towards human Zn7-metallothionein-2 and MTF-1 zinc fingers: potential implications in anticancer drug resistance.

Authors:  Anjala W Bulathge; Rhiza Lyne E Villones; Fabian C Herbert; Jeremiah J Gassensmith; Gabriele Meloni
Journal:  Metallomics       Date:  2022-09-15       Impact factor: 4.636

5.  A bulky platinum triamine complex that reacts faster with guanosine 5'-monophosphate than with N-acetylmethionine.

Authors:  Rebecca D Sandlin; Michael P Starling; Kevin M Williams
Journal:  J Inorg Biochem       Date:  2009-10-23       Impact factor: 4.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.